BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3545116)

  • 1. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
    Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
    Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged treatment with ketanserin in essential hypertension and comparison with metoprolol].
    Finkielman S
    Medicina (B Aires); 1985; 45(4):447-9. PubMed ID: 3916016
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with ketanserin in the treatment of hypertension.
    Palermo A; Mara G; Pizza N; Costantini C; del Rosso G; Assogna G; Libretti A
    J Hypertens Suppl; 1986 Apr; 4(1):S81-3. PubMed ID: 2939219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T; Fillastre JP; Mimran A; de Tréglodé D; Schardt F; Rosenthal T; Grossman E; Rocco S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketanserin and metoprolol in the treatment of essential hypertension].
    Cerasola G; Contorno A; D'Ignoto G; Talamo AR; Vallone A; Zilietti T
    Clin Ter; 1990 Aug 15-31; 134(3-4):193-7. PubMed ID: 2147620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of ketanserin and metoprolol in essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin versus metoprolol in the treatment of essential hypertension.
    Milei J; Lemus J; Bernardiner E
    J Hypertens Suppl; 1986 Apr; 4(1):S77-9. PubMed ID: 2939218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
    Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
    Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in the treatment of essential hypertension. A double blind trial against metoprolol followed by one-year open treatment.
    Milei J; Lemus J; Finkielman S; Nahmod VE; Bernardiner E
    Clin Exp Hypertens A; 1989; 11(3):371-89. PubMed ID: 2663239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of ketanserin in the treatment of arterial hypertension].
    Cricco L
    Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.